Dr. Ralf Brandt
Founder & Chief Executive Officer
A pharmaceutical and oncology research executive with more than 30 years of experience in drug discovery, angiogenesis and preclinical development. Dr. Brandt has advanced more than 50 compounds to clinical studies and brings deep expertise in pharmacology, cell biology, animal model development, GLP compliance and translational research.